Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Catalyst Biosciences aggregated by PharmaCompass.com.

    Client Virtual Booth

    CATALYST BIOSCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Catalyst Biosciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    611 Gateway Blvd., Suite 710 South San Francisco, CA 94080
    Telephone
    Telephone
    650.871.0761
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.catalystbiosciences.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Catalyst Announces Completion of Business Combination With Beijing Continent
    Catalyst Announces Completion of Business Combination With Beijing Continent

    https://www.globenewswire.com//news-release/2023/10/30/2769496/0/en/Catalyst-Biosciences-Announces-Completion-of-Business-Combination-With-Beijing-Continent-Pharmaceuticals-and-Implementation-of-Name-Change-and-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    30 Oct 2023
    Share Share
    Catalyst Clinical Research Acquires Genpro Research
    Catalyst Clinical Research Acquires Genpro Research

    https://www.contractpharma.com/contents/view_breaking-news/2023-07-21/catalyst-clinical-research-acquires-genpro-research/?widget=listSection

    CONTRACT PHARMA
    21 Jul 2023
    Share Share
    Catalyst Global Announces New Board Member Dr. Jotham Musinguzi
    Catalyst Global Announces New Board Member Dr. Jotham Musinguzi

    https://www.accesswire.com/viewarticle.aspx?id=745390&lang=en

    ACCESSWIRE
    27 Mar 2023
    Share Share
    GC Biopharma to Acquire Catalyst Biosciences Rare Disease Hematology Pipeline
    GC Biopharma to Acquire Catalyst Biosciences Rare Disease Hematology Pipeline

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-02/gc-biopharma-to-acquire-catalyst-biosciences-rare-disease-hematology-pipeline/?widget=listSection

    CONTRACT PHARMA
    02 Mar 2023
    Share Share
    Catalyst Biosciences Provides Corporate Update
    Catalyst Biosciences Provides Corporate Update

    https://www.globenewswire.com/news-release/2023/02/28/2616993/0/en/Catalyst-Biosciences-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    28 Feb 2023
    Share Share
    GC Biopharma Signs Agreement with Catalyst Biosciences
    GC Biopharma Signs Agreement with Catalyst Biosciences

    https://www.prnewswire.com/news-releases/gc-biopharma-signs-agreement-with-catalyst-biosciences-for-the-acquisition-of-rare-disease-pipeline-in-hematology-301757256.html

    PR NEWSWIRE
    27 Feb 2023
    Share Share
    Catalyst Receives FDA 510(k) Clearance for its Arthroplasty System
    Catalyst Receives FDA 510(k) Clearance for its Arthroplasty System

    https://www.businesswire.com/news/home/20230209005537/en/Catalyst-Receives-FDA-510-k-Clearance-for-its-Convertible-Stemmed-Total-Shoulder-Arthroplasty-System

    BUSINESSWIRE
    09 Feb 2023
    Share Share
    Catalyst Biosciences Completes First Steps in Reverse Merger Plan
    Catalyst Biosciences Completes First Steps in Reverse Merger Plan

    https://www.globenewswire.com//news-release/2022/12/27/2579778/0/en/Catalyst-Biosciences-Completes-First-Steps-in-Reverse-Merger-Plan.html

    GLOBENEWSWIRE
    27 Dec 2022
    Share Share
    Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share
    Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share

    https://www.globenewswire.com/news-release/2022/08/25/2504556/0/en/Catalyst-Biosciences-Inc-Declares-Special-Cash-Dividend-of-1-43-per-share.html

    GLOBENEWSWIRE
    25 Aug 2022
    Share Share
    Catalyst Biosciences, Inc. Announces Dismissal of JDS1 Litigation
    Catalyst Biosciences, Inc. Announces Dismissal of JDS1 Litigation

    https://www.globenewswire.com/news-release/2022/08/19/2501549/0/en/Catalyst-Biosciences-Inc-Announces-Dismissal-of-JDS1-Litigation.html

    GLOBENEWSWIRE
    19 Aug 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search